The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kharchenko E.P.

Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia

Solov'ev I.A.

Kafedra voenno-morskoĭ i gospital'noĭ khirurgii Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Metastasis and cancer dormancy

Authors:

Kharchenko E.P., Solov'ev I.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2016;5(5): 72‑77

Read: 17674 times


To cite this article:

Kharchenko EP, Solov'ev IA. Metastasis and cancer dormancy. P.A. Herzen Journal of Oncology. 2016;5(5):72‑77. (In Russ.)
https://doi.org/10.17116/onkolog20165572-77

Recommended articles:
Comparison of models for prediction of spontaneous preterm birth. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):10-19
Difficult intu­bation risk asse­ssment in bariatric surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):62-68
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87

References:

  1. Aparicio S, Hidalgo M, KungA L. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer. 2015;15(5):311-316. doi: 10.1038/nrc3944.
  2. Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell. 2013;155(4):750-764. doi: 10.1016/j.cell.2013.10.029.
  3. Oskarsson T, Batlle E, Massagué J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14(3):306-321. doi: 10.1016/j.stem.2014.02.002.
  4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674. doi: 10.1016/j.cell.2011.02.013.
  5. Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19(11):1438-1449. doi: 10.1038/nm.3336.
  6. Kharchenko E. Some immunological aspects of carcinogenesis. Onkologiya. Zhurnal im. P.A. Gertsena. 2013;2(5):70-74. (In Russ.)
  7. Chmielecki J, Meyerson M. DNA sequencing of cancer: what have we learned? Annu Rev Med. 2014;65:63-79. doi: 10.1146/annurev-med-060712-200152.
  8. Pantel K, Denève E, Nocca D, Coffy A, Vendrell JP, Maudelonde T et al. Circulating epithelial cells in patients wi th benign colon diseases. Clin Chem. 2012;58(5):936-940. doi: 10.1373/clinchem.2011.175570.
  9. Podsypanina K, Du YC, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science. 2008;321(5897):1841-1844. doi: 10.1126/science.1161621.
  10. Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13(1):58-68. doi: 10.1016/j.ccr.2007.12.003.
  11. Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell. 2013; 23(5):573-581. doi: 10.1016/j.ccr.2013.04.017.
  12. Cowley AW Jr, Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension. 2012;59(5):899-905. doi: 10.1161/HYPERTENSIONAHA.111.190116.
  13. Wang X, Prince BP, Söber S, Laan M, Snieder H. Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension. Curr Hypertens Rep. 2011;13(6):442-451. doi: 10.1007/s11906-011-0230-y.
  14. van Empel VPM, De Windt LJ, Martins PA. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens. Rep. 2012;14(6):498-509. doi: 10.1007/s11906-012-0310-7.
  15. Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344-352. doi: 10.1038/nature12986.
  16. Vanharanta S, Massagué J. Origins of metastatic traits. Cancer Cell. 2013;24(4):410-421. doi: 10.1016/j.ccr.2013.09.007.
  17. Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274-284. doi: 10.1038/nrc2622.
  18. Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013;19(11):1450-1464. doi: 10.1038/nm.3391.
  19. Demicheli R, Retsky MW, Hrushesky WJ, Baum M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol. 2007;4(12):699-710.
  20. Kharchenko E. Carcinogenesis: the immune system and immunotherapy. Immunologiya. 2011;32(1):50-56. (In Russ.).
  21. Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611-622. doi: 10.1038/nrc3793.
  22. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence forcancer dormancy. Nat Rev Cancer. 2007;7(11):834-846.
  23. Kim RS, Avivar-Valderas A, Estrada Y, Bragado P, Sosa MS, Aguirre-Ghiso JA et al. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PLoS One. 2012;7(4):e35569. doi: 10.1371/journal.pone.0035569.
  24. Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121(1):1-14.
  25. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715-727.
  26. Wang SH, Lin SY. Tumor dormancy: potential therapeutic target intumor recurrence and metastasis prevention. Exp Hematol Oncol. 2013;2(1):29-36. doi: 10.1186/2162-3619-2-29.
  27. Kharchenko EP. Immune privilege: the pathological aspect. Immunologiya. 2009;30(4):249-255. (In Russ.)
  28. Thom R. Catastrophe theory: its present state and future perspectives. Warwick: Springer Verlag; 1974.
  29. Prigogine I, Stengers I. Order out of chaos. Man's new dialogue with nature. Heinemann, London; 1984.
  30. Rini B. Future approaches in immunotherapy. Semin Oncol. 2014;41(Suppl.5):S30-S40. doi: 10.1053/j.seminoncol.2014.09.005.
  31. Weber JS. Current perspectives on immunotherapy. Semin Oncol. 2014;41(Suppl.5):S14-S29. doi: 10.1053/j.seminoncol.2014.09.003.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.